Skip to main content
Daniel Lee, MD, Oncology, New York, NY, New York-Presbyterian Hospital

DanielLeeMD

Oncology New York, NY

Assistant Professor of Medicine, Division of Hematology and Medical Oncology, Columbia University Medical Center

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lee's full profile

Already have an account?

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 2014 - 2017
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2010 - 2016
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2011 - 2014
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 2011

Certifications & Licensure

  • DE State Medical License
    DE State Medical License 2022 - 2025
  • NJ State Medical License
    NJ State Medical License 2022 - 2025
  • PA State Medical License
    PA State Medical License 2018 - 2024
  • TN State Medical License
    TN State Medical License 2016 - 2021
  • NY State Medical License
    NY State Medical License 2014 - 2020
  • IA State Medical License
    IA State Medical License 2017 - 2019
  • CA State Medical License
    CA State Medical License 2012 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology
  • American Board of Urology Urology

Publications & Presentations

PubMed

Journal Articles

  • Improved CNS Exposure to Tocilizumab After Cerebrospinal Fluid Compared to Intravenous Administration in Rhesus Macaques  
    Brigitte C Widemann, Daniel W Lee, Anandani Nellan, Blood

Abstracts/Posters

  • Infectious Complications Associated with CAR T-Cell Therapy
    Daniel W. Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • The First-in-Class Anti-CD47 Antibody Magrolimab (5F9) in Combination with Azacitidine Is Effective in MDS and AML Patients: Ongoing Phase 1b Results
    Daniel J. Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Combination Thioguanine and Decitabine Is Highly Active in Patients with Advanced Myeloid Malignancies: A Single Institution Experience
    Daniel J. Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Professional Memberships

Hospital Affiliations